Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.72% | -- | -- | -- | 85.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.72% | -- | -- | -- | 85.20% |
| Cost of Revenue | 31.09% | -- | -- | -- | 23.76% |
| Gross Profit | 99.27% | -- | -- | -- | 422.89% |
| SG&A Expenses | 38.10% | -- | -- | -- | 80.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.58% | -- | -- | -- | 56.65% |
| Operating Income | -22.85% | -- | -- | -- | -44.03% |
| Income Before Tax | -25.52% | -- | -- | -- | -33.40% |
| Income Tax Expenses | 93.17% | -- | -- | -- | 1,188.00% |
| Earnings from Continuing Operations | -25.61% | -- | -- | -- | -33.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -200.00% |
| Net Income | -25.15% | -- | -- | -- | -34.72% |
| EBIT | -22.85% | -- | -- | -- | -44.03% |
| EBITDA | -22.87% | -- | -- | -- | -57.08% |
| EPS Basic | 48.65% | -- | -- | -- | 97.96% |
| Normalized Basic EPS | 45.97% | -- | -- | -- | 97.92% |
| EPS Diluted | 48.65% | -- | -- | -- | 97.96% |
| Normalized Diluted EPS | 45.97% | -- | -- | -- | 97.92% |
| Average Basic Shares Outstanding | 93.84% | -- | -- | -- | 93.53% |
| Average Diluted Shares Outstanding | 93.84% | -- | -- | -- | 93.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |